DE60309839D1 - Feste lösung einer schwerwasserlöslichen substanz zur oralen verabreichung - Google Patents

Feste lösung einer schwerwasserlöslichen substanz zur oralen verabreichung

Info

Publication number
DE60309839D1
DE60309839D1 DE60309839T DE60309839T DE60309839D1 DE 60309839 D1 DE60309839 D1 DE 60309839D1 DE 60309839 T DE60309839 T DE 60309839T DE 60309839 T DE60309839 T DE 60309839T DE 60309839 D1 DE60309839 D1 DE 60309839D1
Authority
DE
Germany
Prior art keywords
oral administration
water soluble
solid solution
heavy water
soluble substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60309839T
Other languages
English (en)
Other versions
DE60309839T2 (de
Inventor
R M Gorissen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Healthcare Products BV
Original Assignee
Solvay Pharmaceuticals BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharmaceuticals BV filed Critical Solvay Pharmaceuticals BV
Publication of DE60309839D1 publication Critical patent/DE60309839D1/de
Application granted granted Critical
Publication of DE60309839T2 publication Critical patent/DE60309839T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60309839T 2002-02-14 2003-02-11 Feste lösung einer schwerwasserlöslichen substanz zur oralen verabreichung Expired - Lifetime DE60309839T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02075623 2002-02-14
EP02075623 2002-02-14
PCT/EP2003/050014 WO2003068266A1 (en) 2002-02-14 2003-02-11 Oral solid solution formulation of a poorly water-soluble active substance

Publications (2)

Publication Number Publication Date
DE60309839D1 true DE60309839D1 (de) 2007-01-04
DE60309839T2 DE60309839T2 (de) 2007-03-15

Family

ID=27619166

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60309839T Expired - Lifetime DE60309839T2 (de) 2002-02-14 2003-02-11 Feste lösung einer schwerwasserlöslichen substanz zur oralen verabreichung

Country Status (25)

Country Link
US (2) US20050008697A1 (de)
EP (1) EP1476196B1 (de)
JP (1) JP2005517041A (de)
KR (1) KR101014545B1 (de)
CN (1) CN1273194C (de)
AR (1) AR038681A1 (de)
AT (1) ATE345817T1 (de)
AU (1) AU2003208713B2 (de)
BR (1) BR0307278A (de)
CA (1) CA2472744A1 (de)
DE (1) DE60309839T2 (de)
DK (1) DK1476196T3 (de)
ES (1) ES2277635T3 (de)
HK (1) HK1077218A1 (de)
HR (1) HRP20040613A2 (de)
IL (2) IL162883A0 (de)
MX (1) MXPA04007852A (de)
NO (1) NO20043832L (de)
PL (1) PL370452A1 (de)
PT (1) PT1476196E (de)
RU (1) RU2314811C2 (de)
SI (1) SI1476196T1 (de)
UA (1) UA79267C2 (de)
WO (1) WO2003068266A1 (de)
ZA (1) ZA200405608B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004062692A1 (en) * 2003-01-13 2004-07-29 Solvay Pharmaceuticals B.V. Formulation of poorly water-soluble active substances
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) * 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US20050267124A1 (en) * 2004-05-14 2005-12-01 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous producing system and PDEV inhibiitors
US20060159748A1 (en) * 2004-12-23 2006-07-20 Rajesh Jain Oral immediate release formulation of a poorly water-soluble active substance
TW200633713A (en) * 2004-12-23 2006-10-01 Solvay Pharm Bv Oral immediate release formulation of a poorly water-soluble active substance
WO2007054975A1 (en) * 2005-11-08 2007-05-18 Panacea Biotec Ltd Pharmaceutical compositions for the treatment of cardiovascular and other associated disorders
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
JP2007308479A (ja) 2006-04-20 2007-11-29 Shin Etsu Chem Co Ltd 固体分散体製剤
WO2007144418A1 (en) * 2006-06-16 2007-12-21 Solvay Pharmaceuticals B.V. Oral pharmaceutical composition of a poorly water-soluble active substance
KR20090033246A (ko) * 2006-06-22 2009-04-01 솔베이 파마슈티칼스 비. 브이 수용성이 불량한 활성 물질의 경구용 약제학적 조성물
AU2007271088A1 (en) * 2006-07-06 2008-01-10 Ares Trading S.A. An oral pharmaceutical composition of an anilinopyrimidine, its preparation and use thereof
CA2662315A1 (en) * 2006-09-01 2008-03-06 Teva Pharmaceutical Industries Ltd. Solid composites of a calcium receptor-active compound
AR071375A1 (es) * 2008-04-22 2010-06-16 Solvay Pharm Gmbh Formulaciones para ingredientes farmaceuticos activos de permeabilidad deficiente, proceso de preparacion y producto
CA2765033C (en) * 2009-06-12 2020-07-14 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
HUE039328T2 (hu) 2010-08-04 2018-12-28 Gruenenthal Gmbh 6'-Fluor-(N-metil- vagy N,N-dimetil-)-4-fenil-4',9'-dihidro-3'H-spiro[ciklohexán-1,1'pirano[3,4,B]indol]-4-amin összetételû gyógyszerészeti adagolási forma a neuropátiás fájdalom kezelésére
KR101828768B1 (ko) * 2010-08-04 2018-02-13 그뤼넨탈 게엠베하 ６’­플루오로­（Ｎ­메틸­ 또는 Ｎ，Ｎ­디메틸­）­４­페닐­４’，９’­디하이드로­３’Ｈ­스피로［사이클로헥산­１，１’­피라노［３，４，ｂ］인돌］­４­아민을 포함하는 약제학적 투여형
US20180185399A1 (en) * 2015-07-03 2018-07-05 Zhejiang Hisun Pharmaceutical Co., Ltd. Ginsenoside c-k oral solid preparation and preparation method thereof
PL424452A1 (pl) 2018-01-31 2019-08-12 Forty-Four Pharmaceuticals Spółka Z Ograniczoną Odpowiedzialnością Inhibitory obojętnej endopeptydazy (NEP) i ludzkiej rozpuszczalnej endopeptydazy (hSEP) do profilaktyki i leczenia chorób oczu
WO2020112961A1 (en) 2018-11-30 2020-06-04 Chemocentryx, Inc. Capsule formulations

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3359167A (en) * 1965-07-22 1967-12-19 Pfizer & Co C Vitamin a compositions
US4325970A (en) * 1980-10-09 1982-04-20 Hoffmann-La Roche Inc. 15-Acetyl-prostaglandins
NZ224497A (en) * 1987-05-18 1990-04-26 Janssen Pharmaceutica Nv Pharmaceutical composition comprising flunarizine
US5281420A (en) * 1992-05-19 1994-01-25 The Procter & Gamble Company Solid dispersion compositions of tebufelone
DE19510566A1 (de) * 1995-03-23 1996-09-26 Kali Chemie Pharma Gmbh Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19638020A1 (de) * 1996-09-18 1998-03-19 Solvay Pharm Gmbh Die gastrointestinale Durchblutung fördernde Arzneimittel
TW426516B (en) * 1996-12-06 2001-03-21 Fujisawa Pharmaceutical Co An oral pharmaceutical composition in solid dispersion containing water-insoluble tricyclic compounds
ES2229473T3 (es) * 1997-01-30 2005-04-16 Novartis Ag Composiciones farmaceuticas sin aceite que contienen ciclosporina a.
US6008191A (en) * 1997-09-08 1999-12-28 Panacea Biotec Limited Pharmaceutical compositions containing cyclosporin
KR100336090B1 (ko) * 1998-06-27 2002-05-27 윤승원 오일, 지방산 또는 이들의 혼합물을 함유한 난용성 약물의 고형분산제제
DE19906310A1 (de) * 1999-02-16 2000-08-17 Solvay Pharm Gmbh Arzneimittel zur Behandlung von Bluthochdruck
DE19932555A1 (de) * 1999-07-13 2001-01-18 Solvay Pharm Gmbh Arzneimittel mit protektiver Wirkung gegen oxidativ-toxische und insbesondere gegen kardiotoxische Substanzen
US20010036959A1 (en) * 2000-04-03 2001-11-01 Gabel Rolf Dieter Carvedilol-hydrophilic solutions

Also Published As

Publication number Publication date
CN1633307A (zh) 2005-06-29
PL370452A1 (en) 2005-05-30
IL162883A (en) 2009-05-04
AU2003208713A1 (en) 2003-09-04
WO2003068266A1 (en) 2003-08-21
EP1476196A1 (de) 2004-11-17
EP1476196B1 (de) 2006-11-22
CN1273194C (zh) 2006-09-06
KR20040085193A (ko) 2004-10-07
IL162883A0 (en) 2005-11-20
KR101014545B1 (ko) 2011-02-16
BR0307278A (pt) 2004-12-28
CA2472744A1 (en) 2003-08-21
DK1476196T3 (da) 2007-03-05
JP2005517041A (ja) 2005-06-09
US20050008697A1 (en) 2005-01-13
NO20043832L (no) 2004-09-13
AR038681A1 (es) 2005-01-26
HRP20040613A2 (en) 2005-04-30
HK1077218A1 (en) 2006-02-10
UA79267C2 (en) 2007-06-11
ZA200405608B (en) 2005-06-24
RU2314811C2 (ru) 2008-01-20
US20110086844A1 (en) 2011-04-14
AU2003208713B2 (en) 2007-10-18
SI1476196T1 (sl) 2007-04-30
MXPA04007852A (es) 2004-10-15
DE60309839T2 (de) 2007-03-15
RU2004127457A (ru) 2005-04-20
ES2277635T3 (es) 2007-07-16
PT1476196E (pt) 2007-02-28
ATE345817T1 (de) 2006-12-15
AU2003208713B9 (en) 2003-09-04

Similar Documents

Publication Publication Date Title
DE60309839D1 (de) Feste lösung einer schwerwasserlöslichen substanz zur oralen verabreichung
DE69909135D1 (de) Orale zubereitung zur bekämpfung von mundgeruch
ATE296619T1 (de) Feste orale dosierungsform von simethicon
NO2014011I2 (no) Vortioksetin eller et farmasøytisk akseptabelt syreaddisjonssalt dera
DE60026734D1 (de) Brücke zur can-tcp/ip-verbindung
ATE380544T1 (de) Umhüllte feste darreichungsform
CY2007029I1 (el) Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων
DE50212273D1 (de) Pharmazeutische salze von 1-phenyl-3-dimethylamino-propan-verbindungen
DE60213607D1 (de) Einfach beschickbarer spender
DE60139411D1 (de) Gerät zur minimierung der wirkungen einer herzverletzung
DK1326864T3 (da) Sammenföjede aryl- eller heteroarylforbindelser som antiinflammatoriske og analgetiske midler
DE60326451D1 (de) Peptidderivate mit einer thiazepingruppe zur behandlung der hyperlipidämie
DK1438040T3 (da) Farmaceutiske sammensætninger indeholdende mycophenolsyre eller et mycophenolsalt
MA27487A1 (fr) Preparation solide
ATE367831T1 (de) Verfahren zur verbesserung der stabilität einer pharmazeutischen zubereitung
DK1622612T3 (da) Farmaceutisk formulering af natriumsaltet af telmitarsan
IS7481A (is) Epóthílon til gjafar um munn
FI20000780A (fi) Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
DE10108614B4 (de) Wasserlösliches Konzentrat eines stoffwechselbeeinflussenden Wirkstoffes
DK1216226T3 (da) Fremgangsmåde til fremstilling af phenyleddikesyrederivater
FI20020593A (fi) Menetelmä konjugoidun linolihapon valmistamiseksi
ITTO20030669A1 (it) Procedimento per la preparazione di una dispersione acquosa
EE200200213A (et) Suukaudselt manustatav galantamiinilahus
DE502004003170D1 (de) Schmelzformulierte, multipartikuläre orale darreichungsform enthaltend clavulansäure
DE602004016751D1 (de) Orodispersible pharmazeutische zusammensetzung einer antithrombotischen verbindung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition